Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoTN: Onabotulinumtoxin A for the treatment of trigeminal neuralgia
2014-001959-24Phase 2Active
- Sponsor
- Universitätsmedizin Essen
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in trigeminal neuralgia (TN) comparing BoTN-A (BOTOX) arm with Placebo arm (2 arms). Started Jun 2014; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on 2014-001959-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001959-24.